| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 79 |
| 1 | CAPECITABINE | 70 |
| 2 | LETROZOLE | 62 |
| 3 | EVEROLIMUS | 58 |
| 4 | CISPLATIN | 53 |
| 5 | BEVACIZUMAB | 52 |
| 6 | SORAFENIB | 51 |
| 7 | DOCETAXEL | 50 |
| 8 | DOCETAXEL ANHYDROUS | 50 |
| 9 | PEMETREXED DISODIUM | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MATICO, SARSAPARILLA (SMILAX REGELII), THUJA OCCIDENTALIS, UNCARIA TOMENTOSA, PHYLLANTHUS NIRURI, POLYGONUM CUSPIDATUM | 1 | 0.0139 |
| 1 | VARDENAFIL HYDROCHLORIDE | 1 | 0.0122 |
| 2 | HISTAMINE | 1 | 0.0069 |
| 3 | FUTIBATINIB | 1 | 0.0045 |
| 4 | DEMECLOCYCLINE | 1 | 0.0044 |
| 5 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 3 | 0.0029 |
| 6 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 1 | 0.0028 |
| 7 | BRIGATINIB | 10 | 0.0027 |
| 8 | GEFITINIB | 24 | 0.0027 |
| 9 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 1 | 0.0025 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 42 | 0.0019 |
| 1 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 2 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 3 | Estrogen Receptor Antagonist [EPC] | 41 | 0.0010 |
| 4 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 5 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 6 | Aromatase Inhibitor [EPC] | 78 | 0.0007 |
| 7 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 8 | Cannabinoid [EPC] | 5 | 0.0006 |
| 9 | Microtubule Inhibitor [EPC] | 89 | 0.0005 |